Improved process for synthesizing ioversol
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- JIANGSU INST OF NUCLEAR MEDICINE
- Publication Date
- 2007-10-24
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2
Abstract
Description
technical field
[0001] The invention relates to an improved synthesis method of ioversol. The compound is a non-ionic X-ray contrast agent, which is suitable for CT examination, arteriovenous contrast and urography, etc., and belongs to the preparation technology of the non-ionic X-ray contrast agent. Background technique
[0002] Ioversol, the chemical name is N,N'-bis(2,3-dihydroxypropyl)-5-[N-(2-hydroxyethyl)-glycolamide]-2,4,6-tri Iodine-1,3-phthalamide, the trade name of its preparation is Anxili, structural formula (I):
[0003]
[0004] Ioversol has the advantages of large water solubility, low viscosity, low osmotic pressure, and low incidence of adverse reactions. Its preparation, Ioversol Injection, is widely used clinically for cardiovascular angiography and intravenous digital subtraction angiography.
[0005] U.S. Patent No. 4,396,598 discloses a synthetic technique of ioversol, the last step reaction of which is 5-hydroxyacetamido-N, N'-bis(2,3-dihydroxypro...